Using chromatin immunoprecipitation sequencing (ChIP-seq), we showed that SES- and SOX2-bound genomic sites in cancer cells are similar to the endogenous SOX2 footprint in human neural precursors (NPCs) and, to a lesser extent, in embryonic stem cells (ESCs) (Fig. 3D). The gene discussed is SOX2; the disease is cancer.